Abstract
In this study, we observed that Xuebijing (XBJ) injection's cardioprotective advantages may be attributable to its ability to suppress inflammation and apoptosis via inhibiting the TLR4/IKKα-mediated NF-κB and JAK2/STAT3 pathways during sepsis.
Introduction
Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, contributing to nearly 20% of global mortality. A frequent and severe complication is Sepsis-Induced Myocardial Injury (SIMI), which significantly compromises cardiac pumping efficiency. Despite its clinical prevalence, specific preventative therapies for SIMI remain limited. Xuebijing (XBJ) injection, a traditional Chinese herbal remedy approved for sepsis treatment in China, has shown potential in cardiac protection, yet its underlying molecular mechanisms have remained largely unmapped. This study aims to elucidate the specific signaling pathways XBJ modulates to provide cardioprotection.
Materials and Methods
The researchers employed a multi-faceted approach combining in vivo animal modeling and in silico molecular docking:
- Animal Model: Sprague Dawley rats were subjected to the Cecal Ligation and Puncture (CLP) procedure, the gold standard for mimicking human sepsis progression.
- Experimental Groups: Rats were categorized into Sham (control), CLP (sepsis + saline), and XBJ (sepsis + XBJ injection) groups.
- Functional and Molecular Assays: Cardiac function was assessed via echocardiography (LVEF and LVFS). Inflammatory cytokines were measured using ELISA, while protein expression and cell death were quantified through Western Blotting and TUNEL staining, respectively.
- Molecular Docking: Autodock Vina was used to simulate the binding affinity of five key XBJ components (Paeoniflorin, Succinic acid, Quercetin, Naringenin, and Ferulic acid) to JAK2 and STAT3 proteins.
Mechanistic Insights
Dual-Pathway Inhibition
The study identifies that XBJ provides protection by simultaneously targeting two critical signaling axes: the TLR4/NF-κB pathway, which drives the systemic "cytokine storm," and the JAK2/STAT3 pathway, which regulates both inflammatory responses and cell survival.
Molecular Binding Evidence
Computational docking revealed high binding affinities between XBJ’s active monomers and the JAK2/STAT3 proteins. This suggests a physical mechanism where herbal components inhibit these signaling proteins by occupying their active binding sites.
Regulation of Apoptosis
Sepsis typically induces a pro-apoptotic state in cardiomyocytes. XBJ treatment was found to restore the apoptotic balance by downregulating pro-apoptotic proteins (Bax, Caspases) and upregulating anti-apoptotic proteins (Bcl-2, Bcl-xl), thereby preserving heart cell viability.
Results
- Restoration of Cardiac Function: Septic rats treated with XBJ exhibited significantly improved Left Ventricular Ejection Fraction (LVEF) and Fractional Shortening (LVFS) compared to untreated septic models ($p < 0.05$).
- Reduction in Myocardial Damage Markers: Clinical indicators of heart injury, including Lactate Dehydrogenase (LDH), Creatine Kinase (CK), and cardiac Troponin I (cTnI), were markedly reduced in the XBJ group.
- Anti-inflammatory Effects: XBJ administration led to a significant decrease in circulating pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
Limitations and Future Work
While promising, the study notes several limitations: the evaluation was conducted at a single time point (5 days post-CLP), and the use of young adult rats may not fully reflect the physiological response of elderly patients, who are most vulnerable to sepsis. Furthermore, given the complexity of XBJ as a multi-component mixture, additional protective mechanisms likely exist. Future clinical trials are necessary to validate these molecular targets in human populations.
Summary updated